Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 109.37B | 120.03B | 104.64B | 91.51B | 90.90B | 85.71B |
Gross Profit | 112.19B | 0.00 | 104.64B | 91.51B | 91.55B | 85.71B |
EBITDA | 10.69B | 22.29B | 20.07B | 24.40B | 23.16B | 22.51B |
Net Income | 16.92B | 18.04B | 14.28B | 14.49B | 13.40B | 12.96B |
Balance Sheet | ||||||
Total Assets | 7.71T | 7.43T | 8.10T | 7.52T | 7.75T | 7.45T |
Cash, Cash Equivalents and Short-Term Investments | 823.40B | 0.00 | 1.41T | 1.35T | 1.87T | 1.57T |
Total Debt | 646.13B | 703.60B | 1.37T | 837.85B | 1.13T | 900.78B |
Total Liabilities | 7.24T | 7.00T | 7.60T | 707.66B | 7.35T | 7.06T |
Stockholders Equity | 472.82B | 435.45B | 496.92B | 392.03B | 401.85B | 394.68B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 34.40B | -30.39B | -559.28B | 53.00B | 580.59B |
Operating Cash Flow | 0.00 | 38.59B | -25.44B | -556.45B | 55.95B | 583.74B |
Investing Cash Flow | 0.00 | -193.28B | -18.11B | 38.60B | 249.80B | 114.02B |
Financing Cash Flow | 0.00 | -590.64B | 138.16B | -2.91B | -2.82B | -2.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | 1.11T | 14.40 | 6.48% | 2.58% | 11.33% | 20.11% | |
72 Outperform | 607.38B | 12.91 | 7.80% | 2.89% | 7.15% | 44.42% | |
71 Outperform | $224.42B | 13.24 | 3.62% | 2.26% | 3.23% | 15.53% | |
71 Outperform | 456.24B | 10.33 | ― | 1.08% | 33.00% | 80.88% | |
70 Outperform | 849.34B | 11.33 | ― | 3.05% | 10.63% | 12.90% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |